{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:13:59Z","timestamp":1793124839356,"version":"4.5.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>S\u00e9zary syndrome (SS) is a rare neoplasm associated with poor prognosis. Due to the rarity of the disease, large-scale investigations are scarce, while identifying prognostic factors is essential for improving treatment outcomes. The primary objective was to investigate prognostic factors in a large population of SS patients on survival and infections. The secondary objective was to validate a previously suggested prognostic index model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a propensity score-matched retrospective cohort study using real-world data from 1277 patients in the TriNetX database. Risk factors examined included age, elevated lactate dehydrogenase (LDH), anemia, elevated white blood cell count (WBC), sex, and race. Examined outcomes were: 5-year survival, Systemic Inflammatory Response Syndrome (SIRS), sepsis and pneumonia. The prognostic index model was simplified into factors assessable through TriNetX.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age &amp;gt; 60 years, elevated LDH, anemia and elevated WBC were risk factors for 5-year overall survival. Elevated LDH, anemia, elevated WBC and African American\/black race were significantly associated with sepsis. Anemia and elevated WBC were also linked to higher risk of pneumonia. Additionally, we devised and validated a simplified prognostic index model (sPIM) accounting for patient focus on SS (stage IV) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the largest group of SS patients assessed for risk stratification to-date, we confirm age and elevated LDH as risk factors in SS and their applicability in the prognostic index model. This study introduces anemia as a novel risk factor and demonstrates the prognostic value of leukocytosis in SS. While race requires further investigation, sex appears to have no significant impact on survival.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1747618","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:47:48Z","timestamp":1773902868000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic factors in S\u00e9zary syndrome - a retrospective propensity score-matched study on 1277 patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Nadia","family":"Ninosu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Allergology and Venerology, University Medical Center Mannheim\/Ruprecht Karls University of Heidelberg","place":["Mannheim, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Kappenstein","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, University Hospital Frankfurt am Main","place":["Frankfurt am Main, Germany"]},{"name":"Department of Hematology and Oncology, University Hospital of Schleswig-Holstein","place":["L\u00fcbeck, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Gebauer","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University Hospital of Schleswig-Holstein","place":["L\u00fcbeck, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"von Bubnoff","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergology and Venerology, University Hospital Schleswig-Holstein","place":["L\u00fcbeck, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas","family":"von Bubnoff","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University Hospital of Schleswig-Holstein","place":["L\u00fcbeck, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P.","family":"Nicolay","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergology and Venerology, University Medical Center Mannheim\/Ruprecht Karls University of Heidelberg","place":["Mannheim, Germany"]},{"name":"Skin Cancer Unit, German Cancer Research Center","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"B1","article-title":"Epidemiology of mycosis fungoides","volume":"13","author":"Weinstock","year":"1994","journal-title":"Semin Dermatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06337.x","article-title":"Cutaneous lymphomas in Germany: an analysis of the Central Cutaneous Lymphoma Registry of the German Society of Dermatology (DDG)","volume":"5","author":"Assaf","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14706_g","article-title":"S2k-Leitlinie - Kutane Lymphome (ICD10 C82-C86): Update 2021","volume":"20","author":"Dippel","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0305-8","article-title":"Blood and skin-derived Sezary cells: differences in proliferation-index, activation of PI3K\/AKT\/mTORC1 pathway and its prognostic relevance","volume":"33","author":"Cristofoletti","year":"2019","journal-title":"Leukemia"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03480100060031","article-title":"Infections complicating mycosis fungoides and S\u00e9zary syndrome","volume":"267","author":"Axelrod","year":"1992","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17073","article-title":"Infectious events and associated risk factors in mycosis fungoides\/S\u00e9zary syndrome: a retrospective cohort study","volume":"179","author":"Blaizot","year":"2018","journal-title":"Br J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113343","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome - Update 2023","volume":"195","author":"Latzka","year":"2023","journal-title":"Eur J Cancer (Oxf Engl 1990)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer (Oxf Engl 1990)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and S\u00e9zary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025029628","article-title":"A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification","volume":"146","author":"Scarisbrick","year":"2025","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(99)70079-4","article-title":"Prognostic factor analysis in mycosis fungoides\/S\u00e9zary syndrome","volume":"40","author":"Diamandidou","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.2.191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients","volume":"138","author":"Van Doorn","year":"2002","journal-title":"Arch Dermatol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jdermsci.2009.10.010","article-title":"Prognosis of 100 Japanese patients with mycosis fungoides and S\u00e9zary syndrome","volume":"57","author":"Suzuki","year":"2010","journal-title":"J Dermatol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2024.2366631","article-title":"A retrospective study of prognostic factors and treatment outcome in advanced-stage Mycosis Fungoides and Sezary Syndrome","volume":"29","author":"Xu","year":"2024","journal-title":"Hematology"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.063","article-title":"Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides","volume":"60","author":"Sun","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2013.12.018","article-title":"Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008","volume":"14","author":"Nath","year":"2014","journal-title":"Clin Lympho Myeloma Leuk"},{"key":"B22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jaad.2017.04.1137","article-title":"Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database","volume":"77","author":"Su","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2023.12.017","article-title":"Racial Disparities in Mycosis Fungoides\/S\u00e9zary Syndrome-A Single-Center Observational Study of 292 Patients","volume":"24","author":"Gandham","year":"2024","journal-title":"Clin Lympho Myeloma Leuk"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008562","article-title":"S\u00e9zary syndrome originates from heavily mutated hematopoietic progenitors","volume":"7","author":"Harro","year":"2023","journal-title":"Blood Adv"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16071416","article-title":"Real-World Electronic Medical Records Data Identify Risk Factors for Myelofibrosis and Can Be Used to Validate Established Prognostic Scores","volume":"16","author":"Kappenstein","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B26","volume-title":"Guideline on haemoglobin cutoffs to define anaemia in individuals and populations","year":"2024"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17194","article-title":"Infections in mycosis fungoides and S\u00e9zary syndrome are a frequent cause of morbidity and contribute to mortality. What can be done","volume":"179","author":"Scarisbrick","year":"2018","journal-title":"Br J Dermatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V54.4.928.928","article-title":"Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas","volume":"54","author":"Ferraris","year":"1979","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-021-03635-3","article-title":"The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)","volume":"39","author":"Seidel","year":"2021","journal-title":"World J Urol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","article-title":"European Association of Urology Guidelines on Testicular Cancer: 2023 Update","volume":"84","author":"Patrikidou","year":"2023","journal-title":"Eur Urol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.19.2214","article-title":"A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study","volume":"165","author":"Zakai","year":"2005","journal-title":"Arch Intern Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/629204","article-title":"Anemia and blood transfusions in critically ill patients","volume":"2012","author":"Athar","year":"2012","journal-title":"J Blood Transfus"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.3390\/jcm10122556","article-title":"Anemia Is a Risk Factor for the Development of Ischemic Stroke and Post-Stroke Mortality","volume":"10","author":"Heo","year":"2021","journal-title":"J Clin Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041809","article-title":"Anemia of chronic disease","volume":"352","author":"Weiss","year":"2005","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-10-15","article-title":"The prevalence of anemia and its association with 90-day mortality in hospitalized community-acquired pneumonia","volume":"10","author":"Reade","year":"2010","journal-title":"BMC Pulmon Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"A1041","DOI":"10.1016\/j.chest.2019.08.961","article-title":"Anemia as a prognostic factor in patients with severe sepsis and septic shock","volume":"156","author":"Alghoula","year":"2019","journal-title":"CHEST"},{"key":"B41","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1038\/s41598-024-55954-1","article-title":"Association between admission hemoglobin level and prognosis in sepsis patients based on a critical care database","volume":"14","author":"Peng","year":"2024","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2023.12.001","article-title":"Prognostic value of hemoglobin in\u00a0patients with sepsis: A systematic review and meta-analysis","volume":"64","author":"Zhu","year":"2024","journal-title":"Heart Lung"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-013-3131-5","article-title":"Implementation of a multifaceted sepsis education program in an emerging country setting: clinical outcomes and cost-effectiveness in a long-term follow-up study","volume":"40","author":"Noritomi","year":"2014","journal-title":"Intensive Care Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60733-4","article-title":"Community-acquired pneumonia","volume":"386","author":"Prina","year":"2015","journal-title":"Lancet"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2012.06.010","article-title":"Age, race, sex, stage, and incidence of cutaneous lymphoma","volume":"12","author":"Wilson","year":"2012","journal-title":"Clin Lympho Myeloma Leuk"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.006","article-title":"Racial and ethnic disparities in inpatient health care utilization for mycosis fungoides: A cross-sectional analysis of the 2012\u20132017 National Inpatient Sample","volume":"86","author":"Choi","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.06.1193","article-title":"Variations in genetics, biology, and phenotype of cutaneous disorders in skin of color - Part I: Genetic, biologic, and structural differences in skin of color","volume":"87","author":"Brown-Korsah","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.10.029","article-title":"Retrospective analysis of sepsis in cutaneous T-cell lymphoma reveals significantly greater risk in Black patients","volume":"88","author":"Hooper","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"B50","article-title":"Skin cancer in skin of color","volume":"21","author":"Bradford","year":"2009","journal-title":"Dermatol Nurs"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1590\/abd1806-4841.20187134","article-title":"Evaluation of the Cutaneous Lymphoma International Prognostic Index in patients with early stage mycosis fungoides","volume":"93","author":"Amorim","year":"2018","journal-title":"Anais Brasil Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14559","article-title":"The new Cutaneous Lymphoma International Prognostic index (CLIPi) for early mycosis fungoides failed to identify prognostic groups in a cohort of Spanish patients","volume":"175","author":"Sanz-Bueno","year":"2016","journal-title":"Br J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15000","article-title":"Prognostic indicators for mycosis fungoides in a Greek population","volume":"176","author":"Nikolaou","year":"2017","journal-title":"Br J Dermatol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2016.1173210","article-title":"Validation of cutaneous lymphoma international prognostic index (CLIPI) for mycosis fungoides and S\u00e9zary syndrome","volume":"57","author":"Danish","year":"2016","journal-title":"Leuk Lympho"},{"key":"B55","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jid.2019.07.712","article-title":"Overall survival in mycosis fungoides: A systematic review\u00a0and meta-analysis","volume":"140","author":"Mourad","year":"2020","journal-title":"J Invest Dermatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1747618\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:47:50Z","timestamp":1773902870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1747618\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2026.1747618"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1747618","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"article-number":"1747618"}}